{"id":60514,"date":"2024-10-14T12:04:52","date_gmt":"2024-10-14T12:04:52","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/10\/14\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/"},"modified":"2024-10-14T12:04:52","modified_gmt":"2024-10-14T12:04:52","slug":"samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/","title":{"rendered":"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development"},"content":{"rendered":"<div>\n<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2395686\/Samsung_Biologics_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<ul type=\"disc\">\n<li>S-HiCon<sup>TM<\/sup> is designed to maximize drug delivery and stability through high-concentration formulation<\/li>\n<li>The platform can address challenges associated with viscosity and achieve stable liquid formulation for over 200 mg\/mL subcutaneous administration<\/li>\n<\/ul>\n<p><span class=\"legendSpanClass\">INCHEON,\u00a0South Korea<\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 14, 2024<\/span><\/span> \/PRNewswire\/ &#8212; Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), launched today a new high-concentration formulation platform to support the development and manufacturing of high-dose biopharmaceuticals.<\/p>\n<p>S-HiCon<sup>TM<\/sup> can proactively identify unintended pH changes, enhance formulation stability, and reduce viscosity to ensure efficacy and maximize drug delivery. Through optimization of pH, buffer species, and excipients, along with a preliminary &#8216;Concentration Gate Check&#8217; process, the platform tests formulation feasibility in the initial stages to identify favorable candidates and minimize potential risks associated with high concentration development. Additionally, S-HiCon<sup>TM <\/sup>integrates analytical capabilities to ensure that critical formulation challenges associated with viscosity and protein aggregation are addressed (Figure 1). Samsung Biologics has recorded over 200 mg\/mL for liquid formulations, with adequate viscosity and improved stability.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder3219\">\n<p style=\"TEXT-ALIGN: center; WIDTH: 100%\"><a href=\"https:\/\/mma.prnasia.com\/media2\/2529529\/image_revised.html\" target=\"_blank\" rel=\"nofollow noopener\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2529529\/image_revised.jpg?p=medium600\" title=\"\" alt=\"\"><\/a><br \/><span><\/span><\/p>\n<\/p><\/div>\n<p>&#8220;Our new platform will enable us to provide innovative solutions for clients requiring low to ultra-high concentration formulation to develop advanced therapeutics,&#8221; said <span id=\"spanHghlt3c05\"><span class=\"xn-person\">Brian Hosung Min<\/span><\/span>, Executive Vice President and Head of\u00a0CDO Development. &#8220;Samsung Biologics is committed to providing customized services by leveraging our expertise and track record in contract development.&#8221;<\/p>\n<p>The latest offering is part of Samsung Biologics&#8217; continued efforts to provide clients with innovative technologies that enable high-quality development. Leveraging platforms that can increase antibody-dependent cellular cytotoxity (ADCC) activity and enhance upstream process quality, the company is expected to better accommodate clients&#8217; evolving needs and support their pipelines. Visit our website to learn more about our CDO platforms: <a href=\"https:\/\/samsungbiologics.com\/services\/cdo\/overview\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/samsungbiologics.com\/services\/cdo\/overview<\/a><\/p>\n<p><b>About Samsung Biologics Co., Ltd.<\/b><\/p>\n<p>Samsung Biologics (KRX: 207940.KS) is a fully integrated, end-to-end CDMO service provider, offering seamless development and manufacturing solutions from cell line development to final aseptic fill\/finish as well as laboratory testing support for the biopharmaceutical products we manufacture. Our state-of-the-art facilities are CGMP compliant with bioreactors ranging from small to large scales to serve varying client needs. To maximize our operational efficiency and expand our capabilities in response to growing biomanufacturing demand, Samsung Biologics completed\u00a0Bio Campus\u00a0I with Plant 4, offering a combined 604 kL total capacity, and launched\u00a0Bio Campus II\u00a0with the construction of Plant 5, which will be operational in\u00a0April 2025, adding 180 kL biomanufacturing capacity. Additionally, Samsung Biologics America enables the company to work in closer proximity to clients based in the U.S. and\u00a0Europe. We continue to upgrade our capabilities to accommodate our clients by investing in technologies such as an antibody-drug conjugate (ADC) facility, a dedicated mRNA manufacturing facility, and additional aseptic filling capacity. As a sustainable CDMO partner of choice, we are committed to on-time, in-full delivery of the products we manufacture with our flexible manufacturing solutions, operational excellence, and proven expertise.<\/p>\n<p><b>Samsung Biologics Media Contact<br \/><\/b><span class=\"xn-person\">Claire Kim<\/span>, Head of Global Marketing Communications<br \/><a href=\"mailto:cair.kim@samsung.com\" target=\"_blank\" rel=\"nofollow noopener\">cair.kim@samsung.com<\/a>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\">\n<\/p><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation The platform can address challenges associated with viscosity and achieve stable liquid formulation for over 200 mg\/mL subcutaneous administration INCHEON,\u00a0South Korea, Oct. 14, 2024 \/PRNewswire\/ &#8212; Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), launched today a new high-concentration [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-60514","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development\" \/>\n<meta property=\"og:description\" content=\"S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation The platform can address challenges associated wi\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-14T12:04:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/2395686\/Samsung_Biologics_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development\",\"datePublished\":\"2024-10-14T12:04:52+00:00\",\"dateModified\":\"2024-10-14T12:04:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/\"},\"wordCount\":495,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/\",\"name\":\"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-10-14T12:04:52+00:00\",\"dateModified\":\"2024-10-14T12:04:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/","og_locale":"en_US","og_type":"article","og_title":"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development","og_description":"S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation The platform can address challenges associated wi","og_url":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-10-14T12:04:52+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/2395686\/Samsung_Biologics_Logo.jpg?p=medium600"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development","datePublished":"2024-10-14T12:04:52+00:00","dateModified":"2024-10-14T12:04:52+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/"},"wordCount":495,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/","url":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/","name":"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-10-14T12:04:52+00:00","dateModified":"2024-10-14T12:04:52+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/samsung-biologics-launches-high-concentration-formulation-platform-to-accelerate-high-dose-drug-development\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/60514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=60514"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/60514\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=60514"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=60514"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=60514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}